Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;9(1):490-493.e2.
doi: 10.1016/j.jaip.2020.09.052. Epub 2020 Oct 8.

Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City

Hsi-En Ho  1 , Sheryl Mathew  1 , Michael J Peluso  2 , Charlotte Cunningham-Rundles  3
Affiliations

Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City

Hsi-En Ho et al. J Allergy Clin Immunol Pract. 2021 Jan.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immune parameters and inflammatory profile of COVID-19 in antibody-deficient patients. Changes in absolute lymphocyte counts in patients with paired data are shown (n = 12, P value calculated using Wilcoxon matched-pairs signed rank test). Peak inflammatory markers and cytokine profiles during COVID-19 are also shown. ALC, Absolute lymphocyte count; Hypogam., hypogammaglobulinemia. Black solid lines reflect medians for the group, red lines reflect upper limits of normal for individual tests.
Figure E1
Figure E1
Absolute eosinophil counts and absolute neutrophil counts of COVID-19 in antibody-deficient subjects with paired data (n = 12; P value calculated using Wilcoxon matched-pairs signed rank test). Comparison of peak IL-6, D-dimer, fibrinogen, and CRP between those who died and those who recovered. P value calculated using Mann-Whitney test. AEC, Absolute eosinophil count; ANC, absolute neutrophil count.
See this image and copyright information in PMC

References

    1. Quinti I., Lougaris V., Milito C., Cinetto F., Pecoraro A., Mezzaroma I. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. J Allergy Clin Immunol. 2020;146:211–213.e4. - PMC - PubMed
    1. Mira E., Yarce O.A., Ortega C., Fernandez S., Pascual N.M., Gomez C. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma. J Allergy Clin Immunol Pract. 2020;8:2793–2795. - PMC - PubMed
    1. Soresina A., Moratto D., Chiarini M., Paolillo C., Baresi G., Foca E. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Pediatr Allergy Immunol. 2020;31:565–569. - PMC - PubMed
    1. Amanat F., Stadlbauer D., Strohmeier S., Nguyen T.H.O., Chromikova V., McMahon M. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020;26:1033–1036. - PMC - PubMed
    1. Tan L., Wang Q., Zhang D., Ding J., Huang Q., Tang Y.Q. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5:33. - PMC - PubMed

MeSH terms